-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, China’s policies have been encouraging and supporting the orthopedic medical device industry.
For example, the "Guiding Catalogue of Key Products and Services for Strategic Emerging Industries" clearly identified hip/knee/shoulder and other artificial joint prostheses and osteoinductive artificial devices.
Bone implant materials such as bone, artificial bone/metal bone fixation materials, and artificial intervertebral discs are key products of strategic emerging industries
.
At present, driven by multiple factors such as the continuous promotion of favorable policies and the continuous advancement of science and technology, the market capacity of orthopedic medical equipment in China is showing a trend of continuous expansion
.
Statistics show that China's total sales of medical devices in 2020 has reached 734.
1 billion yuan, an increase of 18.
36% year-on-year
.
Among them, the orthopedic implant market scale was 36 billion yuan, a year-on-year increase of 16.
44%, accounting for 4.
90% of the total scale of medical enterprises
.
The industry believes that from the perspective of far lower than the proportion of orthopedic devices in global medical devices, the development prospects of China's orthopedic device industry will be very broad
.
It is worth noting that, in fact, for a long time in the past, China has always had some gaps with the international advanced level in the research and development, production technology and market sales of orthopedic equipment
.
However, in recent years, as the aging trend has intensified, the incidence of orthopedic diseases has increased, people's consumption levels have increased, and the promotion of national medical insurance policies, and other reasons, the domestic orthopedic device market has begun to develop rapidly
.
According to statistics, the market size of orthopedic implant consumables in China in 2018 was 25.
8 billion yuan, and it is expected to grow to 50.
5 billion yuan by 2023.
The compound growth rate for 2019-2023 will be around 14.
19%
.
At present, as the orthopedic equipment market is rapidly increasing, the development of many companies in this field has actually begun to accelerate.
For example, the performance of Kailitai, Akcome Medical, and Dabo Medical have increased significantly in recent years.
.
Take Weigao Orthopedics as an example.
From 2018 to 2020, the company's operating income will be 1.
211 billion yuan, 1.
574 billion yuan and 1.
824 billion yuan, respectively.
The net profit attributable to the owners of the parent company is 324 million yuan, 442 million yuan and 558 million yuan.
Yuan, the compound growth rate reached 22.
71% and 31.
21% respectively
.
However, with the continuous advancement of the centralized procurement of medical consumables, the centralized procurement of orthopedic consumables products is becoming a new trend in the industry after the price of coronary stents has been drastically reduced through centralized procurement.
Tide
.
It is understood that, in fact, the new centralized procurement prices for orthopedic consumables released in many places have proved this trend
.
For example, on July 20th, the information of the Procurement Information Disclosure Conference of the Orthopedic Trauma Medical Consumables Alliance of Henan, Jinxi, Jiangxi, Hubei, Chongqing, Guizhou, Ning, Qingxiang and Hebei Provinces (autonomous regions, municipalities) showed that after negotiations, the entire audience of orthopedic trauma medical consumables The drop reached nearly 90%
.
Mr.
Dreiser, as China’s policies continue to promote the development of the orthopedic medical device industry, the market capacity of orthopedic devices in China will indeed show a trend of continuous expansion
.
However, in the increasingly fierce market competition environment, domestic orthopedic equipment companies also need to find ways to accelerate their competitiveness
.
The industry suggests that relevant companies can continue to focus on the innovative research and development of technology and products, and insist on the continuous update and iteration of products, to consolidate the industry position in the domestic market, enhance the influence of domestic brands, and gradually narrow the gap with international giants and achieve surpass
.
For example, the "Guiding Catalogue of Key Products and Services for Strategic Emerging Industries" clearly identified hip/knee/shoulder and other artificial joint prostheses and osteoinductive artificial devices.
Bone implant materials such as bone, artificial bone/metal bone fixation materials, and artificial intervertebral discs are key products of strategic emerging industries
.
At present, driven by multiple factors such as the continuous promotion of favorable policies and the continuous advancement of science and technology, the market capacity of orthopedic medical equipment in China is showing a trend of continuous expansion
.
Statistics show that China's total sales of medical devices in 2020 has reached 734.
1 billion yuan, an increase of 18.
36% year-on-year
.
Among them, the orthopedic implant market scale was 36 billion yuan, a year-on-year increase of 16.
44%, accounting for 4.
90% of the total scale of medical enterprises
.
The industry believes that from the perspective of far lower than the proportion of orthopedic devices in global medical devices, the development prospects of China's orthopedic device industry will be very broad
.
It is worth noting that, in fact, for a long time in the past, China has always had some gaps with the international advanced level in the research and development, production technology and market sales of orthopedic equipment
.
However, in recent years, as the aging trend has intensified, the incidence of orthopedic diseases has increased, people's consumption levels have increased, and the promotion of national medical insurance policies, and other reasons, the domestic orthopedic device market has begun to develop rapidly
.
According to statistics, the market size of orthopedic implant consumables in China in 2018 was 25.
8 billion yuan, and it is expected to grow to 50.
5 billion yuan by 2023.
The compound growth rate for 2019-2023 will be around 14.
19%
.
At present, as the orthopedic equipment market is rapidly increasing, the development of many companies in this field has actually begun to accelerate.
For example, the performance of Kailitai, Akcome Medical, and Dabo Medical have increased significantly in recent years.
.
Take Weigao Orthopedics as an example.
From 2018 to 2020, the company's operating income will be 1.
211 billion yuan, 1.
574 billion yuan and 1.
824 billion yuan, respectively.
The net profit attributable to the owners of the parent company is 324 million yuan, 442 million yuan and 558 million yuan.
Yuan, the compound growth rate reached 22.
71% and 31.
21% respectively
.
However, with the continuous advancement of the centralized procurement of medical consumables, the centralized procurement of orthopedic consumables products is becoming a new trend in the industry after the price of coronary stents has been drastically reduced through centralized procurement.
Tide
.
It is understood that, in fact, the new centralized procurement prices for orthopedic consumables released in many places have proved this trend
.
For example, on July 20th, the information of the Procurement Information Disclosure Conference of the Orthopedic Trauma Medical Consumables Alliance of Henan, Jinxi, Jiangxi, Hubei, Chongqing, Guizhou, Ning, Qingxiang and Hebei Provinces (autonomous regions, municipalities) showed that after negotiations, the entire audience of orthopedic trauma medical consumables The drop reached nearly 90%
.
Mr.
Dreiser, as China’s policies continue to promote the development of the orthopedic medical device industry, the market capacity of orthopedic devices in China will indeed show a trend of continuous expansion
.
However, in the increasingly fierce market competition environment, domestic orthopedic equipment companies also need to find ways to accelerate their competitiveness
.
The industry suggests that relevant companies can continue to focus on the innovative research and development of technology and products, and insist on the continuous update and iteration of products, to consolidate the industry position in the domestic market, enhance the influence of domestic brands, and gradually narrow the gap with international giants and achieve surpass
.
